港股收评:恒指大跌2%挫547点 药品股跌幅最大 香港零售股逆势普涨
格隆汇11月29日丨今日港股市场呈单边下跌行情,主要股指均大跌。恒指盘前低开早盘急挫,全日表现极其弱势,蓝筹股尽数下跌。恒指大跌547点下破主要均线,呈下降趋势。本月收官,恒指月跌2.08%,国指月跌2.2%。截至今日收盘,恒指跌2.03%,报26346.49点。国指跌2.46%,报10301.82点。主板全日成交894.64亿港元,港股通净流入24.26亿港元。从板块表现看,香港零售股逆势普涨,文娱设施、航天军工、光伏太阳能走强,药品股跌幅居前,餐饮股、建材水泥、猪肉概念、电池股、物管股、手机概念股纷纷下跌。个股方面,恒指、国指成份股无一上涨,石药集团大跌近10%领跌;中生制药大跌近5%;腾讯跌近2%;三桶油、碧桂园、吉利汽车、中国联通、友邦保险等蓝筹全线下挫;港股通标的股周大福逆势大涨近8%,波司登升超5%;阿里巴巴终止三连升,今日收跌2.75%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.